FEATURED MUTUAL FUNDS  
 
 
Better Investing
 
 

-------------------------------------------------------------------------------------------------------

Investing in the small-cap sector requires industry and company knowledge. In addition, investors have to be nimble and ready to withstand daily trading volatility. Investors in Delaware Trend Fund have enjoyed steady returns over the last several years. In the following paragraphs you will learn how Lori Wachs and her team work with the goal of achieving consistent returns.

-------------------------------------------------------------------------------------------------------

Q: Would you start by giving us an overview of your investment style and general philosophy?

A: We are a small-cap growth fund that invests in rapidly growing companies that we have identified as being the leaders in their respective industries. The fund uses a team management approach with dedicated specialists in four broadly defined sectors: technology, business and financial services, healthcare, and consumer. Each sector has a team of two people that is responsible for all the investments within that sector.

The teams are charged with identifying strong, fast-growing companies in fast-growing industries. Before a stock is recommended, the team conducts detailed fundamental research on the company and the specific sub-sector of the industry where it competes.

-------------------------------------------------------------------------------------------------------

Q: What criteria do you use to identify a fast-growing company and how large does a company have to be for it to be included in your small-cap universe?

A: Since the definition of “fast growing” varies by sector and sub-sector, as well as over time, each team has its own yardstick. For the consumer sector, we generally look at companies that have top and bottom line growth of at least 20%.

Within the consumer sector, you don’t get really crazy swings in valuations even when a stock is doing well relative to its industry. For a 25% growth rate, you may get 25 times earnings when the sector is in favor.

In the financial services area, you don’t find companies with growth rates that are that high - especially in banking. But if you look at smaller niche areas, you can sometimes find financial-related companies that have nice growth rates.

One metric we use across all sectors is enterprise value: how much would the reasonable investor pay for this company? That is an important determinant for us in evaluating companies. Another test we use is free cash flow. We look for companies that have a strong enterprise value-to-cash flow ratio.

In terms of size, we consider companies with market caps less than two billion dollars to be small caps. We may go as low as 400 million dollars, but for many obvious reasons that is about as low as one would want to go.

-------------------------------------------------------------------------------------------------------

Q: Could you explain a little bit about your investment process and how you select a specific stock from among 10 companies that are growing at a 20% rate?

A: We look for companies that are not only growing rapidly, but are also leaders in their respective industries. That leadership could be based on a superior product, a proprietary technology, or even unique services offered. The company should have strong market share in the industry, and market share should be increasing.

In the retail space, we look for companies offering unique and differentiated products. For example, there are many companies appealing to the teenage dollar, but we are putting our bet on companies like Urban Outfitters that offer a unique shopping experience and proprietary products.

We also look for companies that successfully erect barriers to entry such as companies that have insulated themselves from Wal-Mart because it’s very difficult to compete with Wal-Mart.

Look at the difficult time the supermarket industry is having. We focus on the long-term outlook for companies rather than how they are currently performing. We try to determine how the companies will perform over a 3-5 year time horizon.

-------------------------------------------------------------------------------------------------------

Q: Once you have identified companies that meet your requirements, what is the catalyst that drives your decision to buy or sell?

A: By the time we are satisfied that a company is fully qualified, the team has already accumulated a substantial amount of background information, research, and related analysis on the company. That information gives us a solid basis from which to decide if their top line or bottom line is fully reflected in the multiple. If we think they are close to a peak, we will watch from the sidelines, but if we believe that they have the potential to increase growth, we may bite.

We also use various technical tools to help us in the buying decision. Our trading teams are very experienced in the growth space. They are on top of the markets and very good at helping select the best points to buy and sell.

While we use computer modeling, we don’t rely on models to make decisions. Instead, we develop our own sense of what is likely to occur, and use the model results as a reality check.

-------------------------------------------------------------------------------------------------------

Q: Turning now to your research process, most managers seem to start with a screening procedure supplemented by fundamental research to generate a primary buy list. Is your process similar to that?

A: No, we do not use screens. Instead, we rely on the experience of our team members. They have been working in their area of expertise long enough to intimately know all the companies in that space. They talk with analysts, attend conferences and IPO meetings and are on top of what is happening in the industry. While the team members each follow an extensive list of companies, they don’t need a screen to identify the ones that are interesting.

-------------------------------------------------------------------------------------------------------

Q: What happens when there is a disagreement within the team whether to buy or sell a stock?

A: Within each team there is a very healthy level of respect for each member’s views; but there are certainly times when one of us will feel more strongly about a particular decision than the other. In most cases, we generally go with the person who has done the work.

We always have two people covering each sector and often they will have differing views. Our experience has been that having someone challenge your views usually results in better decisions. Ultimately, it is the chief portfolio manager, Jerry Frey, who is responsible. He continuously monitors the process and makes sure it runs smoothly. Jerry has a strong background in the healthcare and technology sectors.

-------------------------------------------------------------------------------------------------------

Q: There are two kinds of structures that I have seen in fund management companies: one where the analysts do their work and make a case to the portfolio managers who make the buy and sell decisions, and one where the analysts are the portfolio managers and make the decisions. Which structure most closely describes your team approach?

A: Before we put our team structure in place, our process was similar to your first case. We had a group of analysts who were trying to find ideas to pitch to one of the portfolio managers. It was the portfolio manager who would decide if the name went in or out, and the analyst lost ownership of the name at the playing time. Our current process is just the opposite.

We have eight people conducting research. Six of the eight act as both portfolio managers and analysts. Two are analysts working with the portfolio managers. Everything about the consumer sector is completely controlled by the two portfolio managers. The team as a group conducts the research, works closely with the traders, monitors positions, and decides what to buy or sell. Overseeing the process is someone who makes sure the process runs properly. In addition to playing that role, Jerry also is responsible for diversification and risk management. He acts like a traffic cop to make sure that the portfolio meets its diversification objectives and is in line with the portfolio’s benchmarks.

-------------------------------------------------------------------------------------------------------

Q: Is this fund measured against any specific benchmark or yardstick?

A: We use the Russell 2000 Growth Index as a benchmark.

-------------------------------------------------------------------------------------------------------

Q: Would you describe and discuss your approach to diversification?

A: We generally diversify along the broadly defined sectors. Since we use a bottoms-up approach and are not tied to a specific sector, the names we own tend to be spread out among the sectors. We strictly adhere to our 5% rule — no more that 5% of the portfolio can be held in a single name.

Distribution among the sectors and sub-sectors varies from month to month. We look at the returns by sector on a daily basis, and run a very detailed report by sub-sector weekly using weighted returns. We want to know if our performance is the result of stock selection or sector selection.

We normally average about 80 stocks in the portfolio and have a turnover rate that is more than 70%.

“We strictly adhere to the 5% rule meaning that not more that 5% of the portfolio can be held in a single name.”

-------------------------------------------------------------------------------------------------------

Q: To better understand your approach, could you give a couple of specific examples of how you picked a specific stock, what thinking went into the selection, what happened with the stock, and then how you ended up selling it.

A: An example in the consumer sector might be Coach (COH). At this point we still have the name in our portfolio, so I don’t have the end of the story yet. We first saw the company presented at a conference three years ago. The company had been spun out from Sara Lee a few months before. They were transitioning into a fashion accessory business and had just launched their first logo collection. Within a few weeks of opening the line in Japan, sales of that line had grown to 10% of their total sales. We saw the potential of the line as they moved into their other markets, and believed that it should be able to really move the needle. It has proven to be one of the great success stories in retailing in recent history.

While we did not predict how successful the company would be, as the story unfolded, each step got better and better. They keep expanding market share tremendously and widening their appeal all the way from teenagers to grandmothers. They have designer customers that are trading down to their bags, and customers that don’t typically go into the affordable luxury space trading up.

The company’s operating margin is more than 30 percent and continued growth has given it increasing economies in scale. They still have a lot of room to grow. Even in Japan, where they grew 85% last year, they still only have a 4% market share. The company believes they can expand that to an excess of 10% market share.

So at this point the stock has done well and has very healthy multiples; but you pay for scarcity value. There is not another consumer product company out there that has margins over 30%.

-------------------------------------------------------------------------------------------------------

Q: And why do you continue to own it?

A: When we look at the continuing sales growth and see numbers in the high 20s and lower 30s, it suggests the company still has tremendous momentum behind it. We have seen their new collections and feel that they should resonate well with customers.

-------------------------------------------------------------------------------------------------------

Q: Do you have an example in the non-retail sector?

A: Protein Design Lab (PDLI) in the biotechnology industry would be a good example. The company specializes in monoclonal antibodies. While they didn’t have their own pipeline, they had the technology to humanize antibodies. It is a company that we believe has a terrific future. Historically, antibodies used in the manufacturing process were from mice and can sometimes cause an adverse reaction because they weren’t human. Protein Design Lab’s technology humanizes the antibodies to make them acceptable to humans.

Although the stock had a good run back in 2000 when it peaked just above $80, it has been below $20 recently. Many investors gave up on the company and were not willing to wait the years necessary to bring a product to market, but they were shortsighted. While the company doesn’t have its own drug yet, it has been using its technology in partnership with other companies. They receive a royalty on drugs that are developed using their technology. One drug that has recently been approved is Avastin, which is a colorectal cancer drug developed by Genentech. While PDLI gets only a small royalty, it goes right to the bottom line.

PDLI is also working on their own pipeline. They have a few early stage drugs that are promising but it will take a long time to determine their value.

-------------------------------------------------------------------------------------------------------

Q: Maybe you could describe a stock for which you had high expectation that did not work out, and, specifically, how you reacted to the situation?

A: Often times we take a long-term approach and hold on to stocks even though they are not performing. But when it is clear that the company’s situation has changed, we don’t hesitate to sell.

A good example would be American Italian Pasta. They are a pasta manufacturer, but don’t run restaurants. They recently gave guidance that their outlook had become cloudy due to the low carbohydrate diet craze. We had already started questioning the potential impact of low carb diets, and the management warning was icing on the cake. We sold out. While we still believe in the company, we just felt that there was a better place for our clients’ money than waiting for the diet craze to end or for the company to reinvent itself.

-------------------------------------------------------------------------------------------------------

 
© 2008 advisorselect.com All rights reserved